Extrovis AG is a global Contract Research, Development & Manufacturing Organization (CRDMO) that develops and manufactures complex specialty therapeutics, including sterile antibiotics, oncology and cytotoxic formulations, and female hormone products. The company provides R&D, regulated-market manufacturing (USFDA, EU‑GMP) and supply‑chain and regulatory support across drug substances and finished dosage forms.
AI-generated
Offering
Products & services
Industry:Research & DevelopmentChemical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Sterile cephalosporins, highly potent monobactams, advanced intermediates and controlled substances; with aseptic processing, containment, scale-up, purification and cGMP-compliant production.
Pharmaceutical manufacturing
Oncology solid dosage forms, injectables, topicals and oral liquids as well as cephalosporins, female hormones and general topicals; with development, tech transfer, scale-up, fill-finish, packaging and commercial supply.
Research and Development
Development of new and differentiated FDFs, APIs and intermediates; in addition, drug-device combinations, advanced delivery systems, peptides and sterile injectables.
CDMO partnership and tech transfer
Long-term development and manufacturing partnerships with tech transfer, scale-up, commercial supply, lifecycle management and support for regulated markets.
Comparisons
Extrovis AG in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank Extrovis AG by reviews, experience and specialisations.
Knowledge
No knowledge articles yet
Once Extrovis AG has claimed this profile, we'll publish editorial articles and case studies here together.